Postoperative Pain, Central Sensitization, and Sleep Quality in Breast Cancer Surgery Patients
Investigation of the Relationship Between Postoperative Pain and Both Central Sensitization Severity and Sleep Quality in Patients Undergoing Breast Cancer Surgery
1 other identifier
observational
41
1 country
1
Brief Summary
This prospective observational study aims to investigate whether preoperative central sensitization and sleep quality are associated with acute postoperative pain levels in patients undergoing breast cancer surgery. The study includes 41 female patients scheduled for unilateral breast cancer surgery. Before surgery, participants are evaluated using two self-report questionnaires: the Central Sensitization Inventory (CSI) and the Pittsburgh Sleep Quality Index (PSQI). Based on their scores, participants are categorized into groups according to central sensitization level and sleep quality. After surgery, all participants receive a standardized multimodal analgesia protocol. Pain severity is measured using the Numeric Rating Scale (NRS) at five time points within the first 24 hours: 30 minutes, 2, 6, 12, and 24 hours postoperatively. Additional assessments include sedation level (Ramsay Sedation Scale), nausea and vomiting (Verbal Descriptive Scale), and presence of delirium (Nursing Delirium Screening Scale - NuDESC). The primary question this study seeks to answer is whether higher levels of central sensitization and/or poor sleep quality prior to surgery are predictive of greater acute postoperative pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2025
CompletedFirst Submitted
Initial submission to the registry
June 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedJuly 22, 2025
July 1, 2025
4 months
June 28, 2025
July 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Acute Pain Intensity Measured by the Numeric Rating Scale (NRS)
Postoperative acute pain intensity will be assessed using the Numeric Rating Scale (NRS; range 0-10, where 0 = no pain and 10 = worst imaginable pain) at rest and during movement. Measurements will be taken at 30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours after surgery.
Day 0 (30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours post-surgery)
Secondary Outcomes (3)
Sedation Level Assessed by Ramsay Sedation Scale (RSS)
Day 0 (30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours post-surgery
Postoperative Nausea and Vomiting Severity Scored on a 4-Point Scale (0-3)
Day 0 (30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours post-surgery)
Delirium Assessment Using the Nursing Delirium Screening Scale (NuDESC)
Day 0 (30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours post-surgery)
Study Arms (4)
Good Sleep Quality Group
Participants with Pittsburgh Sleep Quality Index (PSQI) score less than 5, indicating good sleep quality. No intervention is applied to alter sleep patterns; this is a stratification based on preoperative sleep assessment.
Poor Sleep Quality Group
Participants with PSQI score of 5 or greater, indicating poor sleep quality. This group is used to assess the relationship between preoperative sleep disturbance and postoperative pain outcomes. No intervention is applied.
Low Central Sensitization Severity Group
Participants with Central Sensitization Inventory (CSI) score below 40, indicating low central sensitization severity. Used for comparative analysis of postoperative pain scores. No therapeutic intervention applied.
High Central Sensitization Severity Group
Participants with CSI score of 40 or greater, indicating high central sensitization severity This grouping aims to evaluate the effect of central sensitization on postoperative pain perception and analgesic needs. No intervention administered.
Eligibility Criteria
The study population consists of female patients aged 18 to 80 years who were admitted for elective breast cancer surgery at the Department of Anesthesiology and Reanimation, Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty Hospital. Participants were selected consecutively among those scheduled for unilateral simple mastectomy, breast-conserving surgery, or mastectomy combined with immediate breast reconstruction. All surgeries were performed under general anesthesia. Preoperative evaluations and postoperative follow-up (within 24 hours) were conducted in a tertiary-care academic hospital setting. Patients were evaluated using standardized self-report questionnaires.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
İstanbul Üniversitesi-Cerrahpaşa Cerrahpaşa Tıp Fakültesi
Istanbul, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
June 28, 2025
First Posted
July 22, 2025
Study Start
March 13, 2025
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
July 22, 2025
Record last verified: 2025-07